Sixty years ago Geyelin found that many patients with epilepsy remained free of seizures while fasting and for several months after return to a normal diet.' Wilder in the same year suggested that the ketonaemia induced by fasting was responsible for this effect and proposed that a 'ketogenic diet', high in fat and low in carbohydrate, should be used in the treatment of epilepsy.2 This was undertaken in children by Peterman3 and Helmholtz,4 and the best results seemed to occur in the younger age groups. Livingston reported over a period of 41 years that he had controlled myoclonic epilepsy in 54% of 975 cases using the ketogenic diet.5 In spite of these good results, however, the traditional ketogenic diet (87% of dietary energy being provided by fat) has been limited by its unpalatability and nutritional inadequacy in young children. It is also difficult to prepare and has not gained wide acceptance.
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Recently, there has been a resurgence of interest in ketogenic diets as many children with seizuresfor example, tonic-clonic and astatic myoclonic-are not controlled by anticonvulsants used singly or in combination.6 After reports that medium chain triglyceride (MCT) was more ketogenic than fat Huttenlocher et al introduced MCT as an alternative to fat in their ketogenic diet.7 They showed that a ketogenic diet using MCT to provide 60% of dietary energy was at least as effective as a 3:1 ketogenic diet (75% of energy provided by fat) in producing ketosis and controlling seizures. As less carbohydrate restriction was involved such a diet became easier to prepare, was more palatable, and was less lipogenic. Schwartz '6 Huttenlocher showed that ketone concentrations in plasma rose equally with the ketogenic or MCT diets and that this rise was less in older children, in whom the diet seemed less effective.'4 (vii) Huttenlocher et al suggested the possibility of a direct effect of the fatty acids contained in MCT on cerebral excitability.7
We initially attempted to treat 25 children with intractable seizures using the MCT Oil diet but were unable to achieve reasonable palatability, and most patients found it unacceptable. One boy aged 14 with drug resistant absence seizures did persevere with the diet and achieved an impressive improvement in seizure control. After this success we wondered if we might be able to increase the acceptability of the diet by using a proprietary MCT Emulsion as the mechanism of action of this diet would be essentially the same as with the MCT Oil diet, whose efficacy has been well documented.7 8 14 18 Patients and methods In this study MCT Emulsion (Liquigen Scientific Hospital Supplies Ltd, Liverpool) was given. Flavouring was added-namely, Nesquik or synthetic butterscotch-to make the MCT Emulsion more palatable, but several children were able to take it without flavouring. Children admitted to the study were suffering from either astatic myoclonic absence, generalised tonic-clonic, or complex partial seizures, which had failed to respond to the appropriate anticonvulsant given as a single agent. Only children who we considered had a good chance of achieving reasonable function at normal or special school were included in the study.
All children were admitted to hospital and anticonvulsants were withdrawn and were reintroduced only if clinically indicated. Daily energy requirement was assessed on an individual basis by the hospital dietitian. An initial starvation period of one to four days was used to induce ketosis, and then the amount of MCT was slowly increased until 60% of the dietary energy requirement was supplied by MCT Twenty four children tolerated full diet-namely, 60% MCT-18 tolerated 50-58%, two tolerated 45%, and six were unable to tolerate the diet. Of the 44 children who tolerated the diet. eight achieved complete control of seizures (four without anticonvulsants), four achieved excellent control, and 10 achieved good control. Of the remaining 22 children, 13 had poor control and nine showed no improvement. Of the 22 children with good to complete control, however, three whose control of seizures was excellent refused to continue the diet. Fifteen children have been on the diet for two years or more and seven for more than a year. Sixteen children remain on the diet, eight with astatic myoclonic, three with absence, three with generalised tonic-clonic, and two with complex partial seizures. Four children, two with astatic myoclonic and two with absence seizures, have been off the diet nine months or longer without recurrence of seizures.
Of the 17 children over the age of 10, one achieved complete, three excellent, seven good, and four poor control of seizures and two were unable to tolerate the diet. Success was often associated with a high level of patient motivation. A boy aged 10 opted to try the diet as an alternative to temporal lobotomy and achieved good control, and a girl aged 11 who had developed anorexia nervosa on MCT Oil was determined to try MCT Emulsion and achieved excellent control of her absence seizures but required the addition of an anticonvulsant (ethosuximide) to achieve complete control.
In addition, 11 children had considerable difficulties with compliance because they would not take the diet or their parents would not administer it properly, despite the fact that five of them had achieved good control or better. Admission to a residential hospital school was accepted by nine of them, and eight achieved good to complete control. Table. Complex partial All of the eight children in this group (who were aged 9-14 years, with a mean of 10 years) had been tried on carbamazepine, phenytoin, primidone, sodium valproate, and each combined with acetazolamide without reduction of seizure frequency. The results of treatment on MCT diet plus carbamazepine or phenytoin are shown in the Table. Side effects. Mild diarrhoea and abdominal pain were common and were usually alleviated by a temporary reduction of MCT dosage or when MCT was taken in small amounts with food. Side effects led three children, however, who had had excellent control to give up the diet, two of whom have restarted the diet with excellent control.
In 13 children a subjective improvement in mental awareness was observed by parents and nursing and school staff.
One boy aged 10 with severe astatic myoclonic seizures of three years' duration showed a good initial response to the MCT Emulsion diet but later refused to take it. The diet was given by nasogastric tube, but we omitted to give him vitamins through the tube and four weeks later he became blind. His sight was restored four weeks after starting treatment with vitamins. that the MCT diet is worth considering for children with drug resistant seizures and that using a proprietary MCT Emulsion may improve acceptability.
In contrast to previous studies8 9 we withdrew anticonvulsants before introducing the diet. We believe it makes no sense to continue to dispense anticonvulsant treatment that is ineffective, but we insist that withdrawal takes place in hospital. The fact that four children with astatic myoclonic seizures managed better on MCT diet off drugs we think justified this approach and also gives credence to the view that the MCT diet contains 'agents' that have anticonvulsant properties. In addition, we have treated older children with a variety of seizures with some success, and this suggests that the MCT diet should be considered in any child of reasonable intelligence suffering drug resistant seizures rather than reserving it for the younger child as has been suggested. 14 Side effects remain a problem, and we have found that the probable osmotic effects of the diet may be alleviated by giving MCT in regular small amounts with food.
Bilateral optic neuropathy has been reported in two children aged 5-7 who were maintained on a 4:1 ketogenic diet without vitamin B supplements. 19 Blindness occurred 10 months and one year, respectively, after introduction of the diet. Vitamin B supplements and thiamine restored vision in six and 11 weeks, respectively. Our own experience emphasises the importance of giving adequate vitamin B supplements while taking MCT Emulsion. we have attempted to assess control of seizures over the whole duration of treatment, with 22 out of 44 children having received treatment for at least a year at the time of assessment. In their series of 25 children with 'drop seizures', however, 85% had >50% reduction in seizure frequency, whereas in our series of 18 children with astatic myoclonic seizures 50% had >50% reduction in seizure frequency. They provided no information on the eight children they treated with absence seizures, and it is unclear which of the three diets suited the individual children best.
We realise that much of our data on seizure frequency relies on second hand information, but it is difficult to improve on this without either long periods of admission to hospital or prolonged electrical recordings. More reliable records were obtained when nine children were admitted to a residential hospital school for long periods, where teachers and nurses recorded all seizures and the degree of control consequent on this-that is, four complete control, two excellent control, two good control and one would not comply. Two of the children who obtained complete control for six months and then refused the diet did not relapse for three to six months after the diet was withdrawn.
It is our routine to continue the diet and if necessary anticonvulsants for two years after the last seizure. The anticonvulsant is withdrawn slowly and two months later the diet is stopped.
When we see a child with numerous astatic myoclonic seizures in a padded bed for his own protection, drooling, unable to speak or feed himself, and in two weeks on 48% MCT running around the ward, remaining free of seizures for two years and now off treatment for a year without seizures, we begin to ask ourselves if MCT Emulsion should be the first choice treatment for this type of seizure.
